IRulya Therapeutics Inc. (IRLA) stock

IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$39.80+0.02 (+0.05%)

Close on Nov 13, 2026Market cap $40.48MP/E –Yield –

IRulya Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

IRulya Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?